The Best Peptides for Hair Growth in 2026 (Ranked by Evidence)
The best peptides for hair growth ranked by real evidence: GHK-Cu, AHK-Cu, acetyl tetrapeptide-3, biotinoyl tripeptide-1, and what injectable data actually shows.


The best peptides for hair growth, ranked by the strength of hair-specific published evidence, are the copper peptides GHK-Cu and AHK-Cu, followed by the cosmetic signal peptides acetyl tetrapeptide-3 and biotinoyl tripeptide-1, with oral collagen peptides and the experimental peptide PTD-DBM further back. This guide separates what has been tested in humans from what has only been tested in cell culture and mice, and it covers topical, oral, and injectable routes with the actual study numbers behind each one.
The anchor source throughout is Overview of Short Peptides for Hair Loss, a systematic review published in Biomedicines in April 2026 that catalogs more than thirty peptides studied for hair by mechanism and by how far each has progressed in testing.

Best Peptides for Hair Growth: Quick Comparison
Peptides studied for hair fall into four mechanistic groups: pro-angiogenic peptides that increase blood supply to the follicle, Wnt/beta-catenin activators that push follicles back into their growth phase, extracellular matrix peptides that reinforce the structures anchoring the hair, and immunomodulatory peptides aimed at autoimmune hair loss. Copper peptides lead the list because they are the only group with both human data and wide commercial availability.
Peptide | Route and Evidence Stage | Strongest Hair-Specific Finding |
|---|---|---|
GHK-Cu | Topical, injectable; human pilot data | Statistically significant regrowth in 45 men with androgenetic alopecia |
AHK-Cu | Topical; ex vivo and cell culture | Elongated human hair follicles at picomolar to nanomolar doses |
Acetyl tetrapeptide-3 | Topical; supplier-run clinical study | Telogen follicles down 52% versus placebo over 4 months |
Biotinoyl tripeptide-1 | Topical; clinical, combination formula | Hair density measured at 107.2% of baseline |
Egg yolk peptides | Oral; randomized human trial | Higher density than placebo at 250 mg/day over 24 weeks |
Collagen peptides (LMWCP) | Oral; cell culture and mouse | New follicle formation via Wnt/GSK-3beta/beta-catenin |
Thymosin beta-4 | Injectable; rodent only | Activated bulge-region hair follicle stem cells |
PTD-DBM | Topical; mouse only | Outperformed minoxidil in C3H mice when paired with valproic acid |
The pattern in the right-hand column is the honest answer to which peptides work: the ones you can buy in a serum have the weakest mechanistic evidence, and the ones with the most striking results have only been tested on mice.
Copper Peptides for Hair Growth: GHK-Cu and AHK-Cu
Copper peptides are the best-supported peptides for hair growth because they act on the follicle's blood supply, which is the bottleneck in androgenetic alopecia. Both GHK-Cu and AHK-Cu are short copper-binding sequences that raise vascular endothelial growth factor and lower transforming growth factor beta-1, a signaling molecule that pushes follicles out of their growth phase. GHK-Cu has the human data; AHK-Cu has the more specific follicle data.

GHK-Cu: the most studied copper peptide
GHK-Cu is a naturally occurring tripeptide, glycyl-L-histidyl-L-lysine, bound to a copper ion. Loren Pickart isolated it from human plasma in 1973 while studying why young serum regenerated liver tissue better than old serum. Plasma levels fall from roughly 200 ng/mL at age 20 to about 80 ng/mL by age 60, the origin of the argument that supplementing it restores a younger repair signal.
For hair specifically, GHK-Cu increases VEGF production in dermal fibroblasts, drives microvascular angiogenesis, and stimulates collagen synthesis around the follicle. Pickart and Margolina's 2018 gene expression analysis in the International Journal of Molecular Sciences found the peptide modulates more than 4,000 human genes, including large-scale resets of tissue remodeling and anti-inflammatory pathways.
The clinical evidence is real but thin. The 2026 Biomedicines review identifies one Phase I study of a topical GHK-Cu spray in 45 men with androgenetic alopecia that produced statistically significant regrowth. That is a single small trial, not a body of literature, and the review does not report the density percentages.
A topical GHK-Cu spray produced statistically significant hair regrowth in 45 male androgenetic alopecia patients, the only human hair trial for the peptide catalogued in the April 2026 Biomedicines review of short peptides for hair loss.
Peptide Mind's complete GHK-Cu guide covers the skin and wound-healing literature, which is considerably deeper than the hair literature.
AHK-Cu: better follicle data, thinner clinical record
AHK-Cu is alanyl-histidyl-lysine bound to copper, a close structural analog of GHK-Cu. Its hair evidence is more targeted. In a 2007 study in Archives of Pharmacal Research, Pyo and colleagues treated isolated human hair follicles with AHK-Cu at concentrations between 10⁻¹² and 10⁻⁹ M and measured genuine elongation of the follicles ex vivo, alongside increased proliferation of cultured dermal papilla cells.
The mechanism traced through the same axis as GHK-Cu: higher VEGF, lower TGF-beta1, and apoptosis markers shifted toward cell survival. The 2026 review notes AHK-Cu's specific signaling pathway is less characterized than GHK-Cu's, and no in vivo clinical data exists.
This is why AHK-Cu shows up in hair serums and rarely anywhere else. It has the cleanest direct evidence that a copper peptide can make a human hair follicle grow longer, and that evidence comes entirely from follicles in a dish.
Shop research peptides
Live pricing from our top-rated vendor. Prices update as vendor listings change.
Choosing the best copper peptides for hair growth
For topical use, formulation matters more than which of the two copper peptides is on the label. Copper peptides are unstable alongside direct acids and strong antioxidants, so a copper peptide serum applied in the same step as a vitamin C or glycolic product loses potency. Cosmetic concentrations typically sit between 0.5% and 2%.
Formulas pairing AHK-Cu with GHK-Cu are common because the two hit overlapping targets. Neither has been tested head to head for hair, so any ranking between them is inference from mechanism rather than from a comparison trial. Peptide Mind's guide to the best skincare peptides covers copper peptide stability and layering.
Topical Cosmetic Peptides for Hair Growth and Thickness
Cosmetic signal peptides target the hair cycle and the structures that anchor the follicle rather than blood flow. Two dominate the ingredient lists on products marketed for hair growth and thickness: acetyl tetrapeptide-3 and biotinoyl tripeptide-1. Both have human data, and both of those studies were run or funded by the companies selling the ingredient, which is the single most important caveat in this section.

Acetyl tetrapeptide-3
Acetyl tetrapeptide-3 (Ac-KGHK) stimulates production of collagen III, collagen VII, and laminin, the proteins that anchor a follicle into the surrounding dermis. A better-anchored follicle stays in its growth phase longer and sheds less.
The supporting trial gave 30 volunteers with alopecia a daily scalp serum combining acetyl tetrapeptide-3 with red clover extract for four months. Follicles in anagen, the active growth phase, rose 15% against placebo. Follicles in telogen, the shedding phase, fell 52%. The anagen-to-telogen ratio improved by 46%.
In 30 volunteers over four months, a serum containing acetyl tetrapeptide-3 and red clover extract reduced telogen-phase follicles by 52% and improved the anagen-to-telogen ratio by 46% compared with placebo.
Those are strong numbers from a small, ingredient-supplier study of a two-component formula, and the design cannot separate the peptide's effect from the red clover extract's. The 2026 Biomedicines review lists it at Phase I, 30 participants, four months, 100 μM.
Biotinoyl tripeptide-1
Biotinoyl tripeptide-1 is a tripeptide bound to biotin, formulated for keratin production and hair shaft strength. In dermal papilla cell work, it increased proliferation, reduced reactive oxygen species, and lowered 5-alpha-reductase expression, the enzyme that converts testosterone into DHT. The review describes those cell-level effects as comparable to minoxidil.
Its clinical data comes from a combination serum with Phyllanthus emblica fruit extract, applied twice daily, where hair density was measured at 107.2% of baseline in men with hair loss. That is a 7.2% gain, and again from a formula rather than the isolated peptide.
What topical peptides realistically deliver
Topical cosmetic peptides are retention and thickness tools, not regrowth drugs. The measurable wins in these studies are reduced shedding, a longer growth phase, and slightly greater density over four to six months of daily use. None produced the density change minoxidil or finasteride produce in their registration trials.
That matters for anyone searching for the best peptides for hair growth and thickness. Thickness, meaning shaft diameter and the proportion of follicles actively growing, is where the peptide evidence is strongest. Regrowth from a bald scalp is not.
Injectable Peptides for Hair Growth: What the Evidence Supports
Injectable peptides for hair growth have far less direct evidence than the topical route, and none of the commonly discussed injectables has a completed human hair trial. This is the part of the topic cosmetic guides skip, so here is what the research actually shows.

Shop research peptides
Live pricing from our top-rated vendor. Prices update as vendor listings change.
Injectable GHK-Cu
GHK-Cu is the one injectable peptide with any human hair data at all, and that data comes from the topical spray trial described above, not from injection. Subcutaneous GHK-Cu is used in research settings at 0.5 to 1 mg daily, cycled in blocks of four to eight weeks, which is the same dosing range applied to its skin and wound-repair research.
The case for injecting is systemic distribution. The case against is that the target tissue is the scalp dermis, which topical application reaches directly, and no published study has compared the two routes for hair. The peptide dosage calculator converts vial size to injection volume for research protocols.
GHK-Cu also appears in multi-peptide research blends. Peptide Mind's Glow peptide guide covers the GHK-Cu, BPC-157, and TB-500 combination and what evidence exists for each component.
Thymosin beta-4 and TB-500
Thymosin beta-4 is a 43-amino acid peptide that regulates cell migration. Its hair credential is a 2004 study in The FASEB Journal by Philp and colleagues, which found it stimulated hair growth in rats and mice by activating stem cells in the follicle bulge region. Clonogenic keratinocytes from rat vibrissa follicles showed increased migration and differentiation at nanomolar concentrations.
That study is the origin of every claim connecting TB-500 to hair. Twenty-two years later there is still no human hair trial, and the 2026 review mentions thymosin beta-4 only in its historical section. TB-500 is a synthetic fragment of thymosin beta-4 rather than the full peptide, a distinction Peptide Mind covers in TB-500 vs thymosin beta-4.
Growth hormone secretagogues
Sermorelin, ipamorelin, and CJC-1295 appear in hair discussions because IGF-1 extends the anagen phase, and these peptides raise IGF-1 indirectly by stimulating growth hormone release. The follicle biology is genuine. The clinical evidence is not: no trial has measured hair density as an endpoint for any of them.
Treat hair as a possible secondary effect of a growth hormone protocol run for other reasons, not as a reason to start one. This is the weakest link in the injectable category and the one most often oversold.
Oral Peptides for Hair Growth
Oral peptides for hair growth work through nutrition and systemic signaling rather than direct follicle contact, and two have randomized human data. Both come from food-derived hydrolysates rather than the synthetic research peptides discussed above.
Water-soluble egg yolk peptides produced the cleanest oral result in the 2026 review: 76 subjects taking 250 mg per day for 24 weeks reached significantly higher hair density than placebo. That is the largest and longest human trial of any peptide in this guide.
Low molecular weight collagen peptides are fish-derived hydrolysates. A 2023 study in the Journal of Microbiology and Biotechnology from Chung-Ang University found LMWCP increased proliferation in human dermal papilla cells, raised secretion of EGF, FGF-4, and FGF-6, and generated new hair follicles in a dose-dependent mouse patch assay by activating the Wnt/GSK-3beta/beta-catenin pathway.
The commercial version of this story is oversold. Most collagen supplements marketed for hair are not LMWCP, and the mechanism in the study is a signaling pathway effect, not a matter of eating protein that becomes hair.
Experimental Hair Peptides and What PP405 Actually Is
Two names come up constantly in hair loss discussion, and they need separating: PTD-DBM is a genuine experimental peptide with mouse data, and PP405 is not a peptide at all.
PTD-DBM
PTD-DBM disrupts the interaction between CXXC5 and Dishevelled, releasing a brake on the Wnt/beta-catenin pathway that controls the hair cycle. In a 2017 study in the Journal of Investigative Dermatology, Lee and colleagues at Yonsei University found that topical 2 mM PTD-DBM combined with 500 mM valproic acid outperformed 100 mM minoxidil in C3H mice, with upregulated beta-catenin, keratin 14, and PCNA.
Beating minoxidil in mice is a real result and a long way from a treatment. There is no human trial, no approved product, and no clinical dosing for the material sold online under this name.
Shop research peptides
Live pricing from our top-rated vendor. Prices update as vendor listings change.
PP405 is a small molecule, not a peptide
PP405 is frequently listed among hair growth peptides. It is not one. It is a small-molecule inhibitor of the mitochondrial pyruvate carrier, developed at UCLA and licensed to Pelage Pharmaceuticals, which reactivates dormant follicle stem cells by shifting their metabolism.
Its data is the strongest in this entire article. In a Phase 2a trial of 78 patients applying it topically once daily for four weeks, 31% of treated men with more advanced hair loss showed a greater than 20% increase in hair density at week eight, against 0% of the placebo group. It moved toward Phase 3 in 2026.
In Pelage Pharmaceuticals' Phase 2a trial of 78 patients, 31% of treated men with more advanced hair loss achieved more than a 20% hair density increase by week eight, compared with 0% on placebo.
PP405 is the benchmark, and no peptide in this guide has produced a comparable result. Understanding what a peptide actually is makes it easier to spot a compound marketed into the wrong category.
Peptides for Hair Growth in Women
Peptides for hair growth in women are studied in the same trials as men, with one meaningful difference: the two clinical studies with the best design for female pattern loss are the topical cosmetic ones, not the injectables. The acetyl tetrapeptide-3 trial enrolled a mixed volunteer group, and the egg yolk peptide trial ran across 76 subjects of both sexes.
Female pattern hair loss involves diffuse thinning across the crown rather than the receding pattern typical in men. Peptides that work through blood supply and follicle anchoring, meaning the copper peptides and acetyl tetrapeptide-3, do not depend on androgen pathways, which is why the same mechanism applies in both sexes.
Growth hormone secretagogues carry the most caution for women, because they alter systemic hormone signaling for a hair benefit that has never been measured. Peptide Mind's guide to the best peptides for women covers those trade-offs across goals beyond hair.
Timelines, Side Effects, and Sourcing
Hair responds slowly because the follicle cycle is slow. A follicle pushed into anagen today does not produce visible length for months, which is why every credible study in this guide runs sixteen weeks or longer.
Time Point | What the Studies Measured |
|---|---|
Weeks 0 to 4 | No visible change; cell-level shifts only |
Weeks 8 to 12 | Reduced shedding; anagen-to-telogen ratio begins to shift |
Weeks 16 to 24 | Measurable density change in the acetyl tetrapeptide-3 and egg yolk peptide trials |
Beyond 24 weeks | No peptide hair study in the 2026 review ran longer |

Side effects
Topical copper peptides are well tolerated in cosmetic use. Reported effects are limited to local irritation, temporary scalp redness, and, at high concentrations over long periods, the theoretical concern of copper accumulation. Some users report shedding in the first weeks, consistent with follicles cycling out of telogen, though no study has quantified this for peptides.
Injectable peptides carry the risks of any subcutaneous injection: site reactions, bruising, and contamination if sterile technique is poor. None of the injectable peptides discussed here is FDA approved for hair loss or any other indication, and they are sold as research chemicals.
Sourcing and quality
Peptide purity varies widely between suppliers, and hair peptides are a category where mislabeling is common. Look for a certificate of analysis with HPLC purity above 98% and mass spectrometry confirming the molecular weight, dated to the specific lot rather than a generic sample. Copper peptides degrade faster than uncomplexed peptides, so store them cold and away from light.
Costs range widely across the category. Peptide Mind tracked 177 live vendor prices and found the same peptide varying by up to 8x between suppliers, which makes price a poor signal of quality in either direction.
Frequently Asked Questions
Shop research peptides
Live pricing from our top-rated vendor. Prices update as vendor listings change.
Do peptides for hair growth really work?
Some do, modestly, in the studies that exist. Acetyl tetrapeptide-3 reduced telogen follicles by 52% over four months, and oral egg yolk peptides beat placebo on density across 76 subjects over 24 weeks. Both are real results from small trials, most of them run by the ingredient supplier. No peptide has matched minoxidil or finasteride in a comparable trial.
What is the best peptide for hair growth?
GHK-Cu has the strongest combination of human data and mechanistic support, with one Phase I trial in 45 men with androgenetic alopecia showing statistically significant regrowth. AHK-Cu has more specific follicle evidence but only ex vivo. For topical use in a finished product, acetyl tetrapeptide-3 has the best-documented clinical numbers.
How long do peptides take to work for hair?
Sixteen to twenty-four weeks before density changes are measurable. The acetyl tetrapeptide-3 study saw density rise from month two, and the egg yolk peptide trial ran a full 24 weeks. Reduced shedding usually shows first, around weeks 8 to 12. No peptide hair study in the 2026 Biomedicines review ran beyond 24 weeks.
Can GHK-Cu regrow hair?
GHK-Cu produced statistically significant regrowth in one Phase I trial of 45 men with androgenetic alopecia, using a topical spray. That is a single small study without published density percentages. The mechanism is well characterized, involving increased VEGF and follicular angiogenesis, but the human evidence base is one trial, not a literature.
Are injectable peptides for hair growth better than topical?
No published study has compared the two routes for hair, and topical has more human hair data than injectable. Every human hair trial in the 2026 review used a topical or oral route. Injectable GHK-Cu, thymosin beta-4, and growth hormone secretagogues have no completed human hair trial between them.
Do peptides for hair growth have side effects?
Topical copper peptides cause local irritation and temporary scalp redness in some users, with copper accumulation a theoretical concern at high long-term concentrations. Injectable peptides add injection site reactions, bruising, and contamination risk. None of the injectable peptides discussed here is FDA approved for hair loss.
Can peptides cause hair shedding?
Some users report increased shedding in the first weeks of topical copper peptide use, which is consistent with follicles being pushed out of the telogen phase into a new growth cycle. No published study has quantified shedding as an endpoint for hair peptides, so this remains an anecdotal pattern rather than a documented effect.
Where the Hair Peptide Evidence Actually Points
The best peptides for hair growth today are the copper peptides, GHK-Cu and AHK-Cu, backed by one small human trial and solid follicle-level data, with acetyl tetrapeptide-3 the strongest option in a finished topical product. Everything more dramatic in this category, PTD-DBM included, has been tested on mice, and the compound with the best hair data of all, PP405, is not a peptide.
Explore the full GHK-Cu research profile for the mechanism, dosing, and skin literature behind the most studied peptide on this list.
References
Fan et al. "Overview of Short Peptides for Hair Loss." Biomedicines, 14(4):864, 2026. PMC13113319.
Pyo HK, Yoo HG, Won CH, et al. "The effect of tripeptide-copper complex on human hair growth in vitro." Archives of Pharmacal Research, 30(7):834-839, 2007. PubMed 17703734.
Pickart L, Margolina A. "Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data." International Journal of Molecular Sciences, 19(7):1987, 2018. PMC6073405.
Lee SH, Kim MY, Kim HY, et al. "Targeting of CXXC5 by a Competing Peptide Stimulates Hair Regrowth and Wound-Induced Hair Neogenesis." Journal of Investigative Dermatology, 137(11):2260-2269, 2017. PubMed 28595998.
Philp D, Nguyen M, Scheremeta B, et al. "Thymosin beta4 increases hair growth by activation of hair follicle stem cells." The FASEB Journal, 18(2):385-387, 2004. PubMed 14657002.
Kim Y, Lee JO, Lee JM, et al. "Low Molecular Weight Collagen Peptide (LMWCP) Promotes Hair Growth by Activating the Wnt/GSK-3β/β-Catenin Signaling Pathway." Journal of Microbiology and Biotechnology, 33(11), 2023. PMC10840484.
Pelage Pharmaceuticals. "Positive Phase 2a Clinical Trial Results for PP405 in Regenerative Hair Loss Therapy." Press release, 2025.
Disclaimer: The information on Peptide Mind is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. The peptides discussed are unapproved research chemicals for laboratory and research use only, not for human consumption. These statements have not been evaluated by the FDA, and nothing on this site is intended to diagnose, treat, cure, or prevent any disease. By accessing this site, you confirm you are 21 or older and agree to our Terms of Service.
Add a comment
This will be publicly visible.
Your email address will not be published.
Your comment will be reviewed by an admin before it is published.














